Balance Sheet Garofalo Health Care S.p.A.

Equities

GHC

IT0005345233

Healthcare Facilities & Services

Market Closed - Borsa Italiana Other stock markets 11:45:00 2025-06-20 am EDT			5-day change	1st Jan Change
5.030 ^EUR	-3.27%		-3.08%	-7.88%

Jun. 20	Markets Rise, But Caution Persists Amid Middle East Tensions	AN
Jun. 20	Futures Point to Technical Rebound for European Markets	AN

0ffbe493acc0f0e06401002.FgZOLow_LRhlQuIx7vuL6QxCMqZATo-TkQa4C_QWc24.b3R3ZfVSfC9dd4ZEm7PsiFsQSO8XONfl-EjUYcFaJTxlQjge-Upucggdrw

Published financial data: GAROFALO HEALTH CARE S.P.A.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	207M	278M	315M	361M	462M
Other Revenues, Total	-	3.82M	5.28M	5.16M	5.59M
Total Revenues	207M	282M	320M	366M	468M
Cost of Goods Sold, Total	163M	218M	249M	285M	368M
Gross Profit	43.39M	63.24M	71.29M	80.68M	99.83M
Selling General & Admin Expenses, Total	1.71M	670K	829K	890K	1.01M
Depreciation & Amortization - (IS)	11.59M	15.52M	18.36M	21.44M	25.33M
Other Operating Expenses	9.51M	13.23M	12.23M	14.47M	23.77M
Other Operating Expenses, Total	22.81M	29.42M	31.42M	36.8M	50.11M
Operating Income	20.58M	33.83M	39.87M	43.88M	49.72M
Interest Expense, Total	-2.54M	-4.21M	-4.2M	-10.29M	-13.92M
Interest And Investment Income	3K	3K	19K	282K	1.07M
Net Interest Expenses	-2.53M	-4.21M	-4.18M	-10.01M	-12.86M
Income (Loss) On Equity Invest.	227K	213K	129K	173K	123K
Other Non Operating Income (Expenses)	1.72M	-245K	-239K	-461K	-709K
EBT, Excl. Unusual Items	20M	29.59M	35.57M	33.58M	36.28M
Gain (Loss) On Sale Of Investments	-	-	-	-	-15K
Gain (Loss) On Sale Of Assets	29K	58K	137K	84K	610K
Asset Writedown	-220K	-187K	-599K	-1.67M	-826K
Insurance Settlements	-	-	188K	34K	35K
Legal Settlements	-3.17M	-2.73M	-3.78M	-2.39M	-5.4M
Other Unusual Items	-2.54M	-2.74M	-2.64M	-703K	-
EBT, Incl. Unusual Items	14.1M	23.99M	28.88M	28.93M	30.68M
Income Tax Expense	2.32M	5.14M	7.44M	8.06M	8.84M
Earnings From Continuing Operations	11.78M	18.84M	21.43M	20.87M	21.85M
Net Income to Company	11.78M	18.84M	21.43M	20.87M	21.85M
Minority Interest	-3K	-9K	-7K	-74K	-146K
Net Income - (IS)	11.78M	18.83M	21.43M	20.8M	21.7M
Net Income to Common Incl Extra Items	11.78M	18.83M	21.43M	20.8M	21.7M
Net Income to Common Excl. Extra Items	11.78M	18.83M	21.43M	20.8M	21.7M
Per Share Items
Net EPS - Basic	0.14	0.21	0.24	0.23	0.25
Basic EPS - Continuing Operations	0.14	0.21	0.24	0.23	0.25
Basic Weighted Average Shares Outstanding	81.61M	89.23M	88.9M	88.55M	88.47M
Net EPS - Diluted	0.14	0.21	0.24	0.18	0.24
Diluted EPS - Continuing Operations	0.14	0.21	0.24	0.18	0.24
Diluted Weighted Average Shares Outstanding	81.61M	89.23M	88.9M	88.55M	88.47M
Normalized Basic EPS	0.15	0.21	0.25	0.24	0.25
Normalized Diluted EPS	0.15	0.21	0.25	0.24	0.25
Dividend Per Share	-	-	-	-	0.09
Payout Ratio	-	-	-	-	-
Supplemental Items
EBITDA	29.57M	46.44M	55.05M	61.6M	70.92M
EBITA	20.7M	34.14M	40.12M	44.09M	49.92M
EBIT	20.58M	33.83M	39.87M	43.88M	49.72M
EBITDAR	31.27M	47.11M	55.88M	62.49M	71.93M
Total Revenues (As Reported)	211M	284M	323M	369M	471M
Effective Tax Rate - (Ratio)	16.42	21.45	25.77	27.85	28.8
Current Domestic Taxes	-	5.4M	-	7.44M	7.37M
Total Current Taxes	3.41M	5.4M	6.44M	7.44M	7.37M
Deferred Domestic Taxes	-	-428K	-	417K	1.05M
Total Deferred Taxes	-2.46M	-428K	-1.3M	417K	1.05M
Normalized Net Income	12.5M	18.48M	22.22M	20.91M	22.53M
Interest on Long-Term Debt	1.66M	2.23M	3.13M	7.69M	2.22M
Non-Cash Pension Expense	65K	65K	45K	-	-
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	-	-	205K	199K	192K
Net Rental Expense, Total	1.71M	670K	829K	890K	1.01M
Imputed Operating Lease Interest Expense	283K	148K	155K	362K	440K
Imputed Operating Lease Depreciation	1.42M	522K	674K	528K	567K
Maintenance & Repair Expenses, Total	4.09M	4.7M	5.16M	6.01M	7.32M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	24.81M	41.24M	31.38M	22.68M	26.66M
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	24.81M	41.24M	31.38M	22.68M	26.66M
Accounts Receivable, Total	61.41M	74.72M	76.48M	101M	113M
Other Receivables	4.03M	5.5M	4.66M	10.49M	7.72M
Total Receivables	65.44M	80.22M	81.14M	111M	121M
Inventory	3.49M	4.32M	4.24M	5.58M	6.07M
Prepaid Expenses	1.11M	1.4M	1.58M	-	-
Other Current Assets, Total	2.8M	2.76M	3.05M	5.51M	11.18M
Total Current Assets	97.65M	130M	121M	145M	164M
Net Property Plant And Equipment	159M	217M	222M	253M	294M
Long-term Investments	928K	1.28M	826K	3.78M	1.36M
Goodwill	54.44M	70.26M	91.39M	156M	91.54M
Other Intangibles, Total	140M	196M	196M	219M	281M
Deferred Tax Assets Long-Term	5.14M	9.66M	10.62M	14.85M	14M
Other Long-Term Assets, Total	2.4M	2.52M	3.73M	4.06M	3.6M
Total Assets	460M	627M	646M	796M	850M
Liabilities
Accounts Payable, Total	35.86M	46.24M	51.1M	87.85M	86.41M
Accrued Expenses, Total	10.15M	13.91M	14.14M	18.35M	18.46M
Short-term Borrowings	12.18M	19.11M	16.28M	16.72M	26.67M
Current Portion of Long-Term Debt	16.89M	21.5M	22.15M	42.15M	1.13M
Current Portion of Leases	3.5M	4.84M	5.86M	5.27M	4.9M
Current Income Taxes Payable	1.33M	3.04M	2.45M	3.47M	2.75M
Other Current Liabilities	15.63M	21.56M	19.25M	30.6M	4.53M
Total Current Liabilities	95.54M	130M	131M	204M	145M
Long-Term Debt	70.49M	117M	110M	142M	201M
Long-Term Leases	19.36M	21.56M	21.62M	21.94M	22.44M
Pension & Other Post Retirement Benefits	11.05M	12.07M	13.6M	19.5M	15.95M
Deferred Tax Liability Non Current	47.79M	67.93M	67.36M	74.77M	104M
Other Non Current Liabilities	12.4M	17.47M	22.39M	32.75M	29.16M
Total Liabilities	257M	366M	367M	495M	517M
Common Stock, Total	28.7M	31.57M	31.57M	31.57M	31.57M
Additional Paid In Capital	67.61M	107M	107M	107M	107M
Retained Earnings	68.24M	87.08M	109M	130M	151M
Treasury Stock	-1.72M	-4.87M	-6.11M	-7.6M	-8.11M
Comprehensive Income and Other	40.33M	40.12M	38.23M	38.7M	40.94M
Total Common Equity	203M	260M	279M	299M	322M
Minority Interest	66K	262K	83K	2M	10.75M
Total Equity	203M	261M	279M	301M	333M
Total Liabilities And Equity	460M	627M	646M	796M	850M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	89.81M	89.23M	88.9M	88.55M	88.47M
ECS Total Common Shares Outstanding	81.61M	89.23M	88.9M	88.55M	88.47M
Book Value / Share	2.49	2.92	3.14	3.38	3.64
Tangible Book Value	8.59M	-5.64M	-8.36M	-76.38M	-50.59M
Tangible Book Value Per Share	0.11	-0.06	-0.09	-0.86	-0.57
Total Debt	122M	184M	176M	228M	256M
Net Debt	97.62M	142M	145M	205M	229M
Debt Equivalent Oper. Leases	13.66M	5.36M	6.63M	7.12M	8.06M
Minority Interest, Total (Incl. Fin. Div)	66K	262K	83K	2M	10.75M
Equity Method Investments, Total	878K	809K	735K	1.29M	1.28M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	3.49M	4.32M	4.24M	5.58M	6.07M
Full Time Employees	1.19K	1.86K	1.91K	2.77K	2.34K
Part Time Employees	245	-	-	-	364
Accumulated Allowance for Doubtful Accounts (Supple)	5.72M	6.64M	7.06M	11.46M	11.98M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	11.78M	18.83M	21.43M	20.8M	21.7M
Depreciation & Amortization - CF	11.16M	14.85M	17.42M	20.35M	23.9M
Amortization of Goodwill and Intangible Assets - (CF)	122K	312K	256K	213K	208K
Depreciation & Amortization, Total	11.28M	15.16M	17.68M	20.56M	24.11M
Amortization of Deferred Charges, Total - (CF)	303K	359K	688K	878K	1.23M
(Income) Loss On Equity Investments - (CF)	-227K	-213K	-129K	-173K	-123K
Provision and Write-off of Bad Debts	220K	187K	599K	1.67M	826K
Other Operating Activities, Total	-172K	-808K	5.02M	846K	1.42M
Change In Accounts Receivable	-6.51M	-2.71M	-1.91M	4.96M	-12.67M
Change In Inventories	-422K	341K	191K	170K	-490K
Change In Accounts Payable	-99K	-881K	3.88M	-2.54M	-1.44M
Change in Other Net Operating Assets	6.8M	6.04M	-3.56M	2.83M	442K
Cash from Operations	22.96M	36.31M	43.87M	50.01M	34.99M
Capital Expenditure	-11M	-23.2M	-13.84M	-15.44M	-18.29M
Sale of Property, Plant, and Equipment	595K	326K	316K	271K	791K
Cash Acquisitions	-12M	-67.68M	-20.88M	-49.96M	-
Sale (Purchase) of Intangible assets	-1.14M	-1.47M	-1.13M	-1.71M	-3.3M
Investment in Marketable and Equity Securities, Total	-	-388K	-169K	-1.14M	2.45M
Other Investing Activities, Total	308K	281K	203K	80K	-
Cash from Investing	-23.24M	-92.13M	-35.5M	-67.9M	-18.36M
Short Term Debt Issued, Total	-	6.93M	-	431K	-
Long-Term Debt Issued, Total	14.27M	180M	16.59M	40.68M	178M
Total Debt Issued	14.27M	187M	16.59M	41.11M	178M
Short Term Debt Repaid, Total	-2.5M	-	-2.82M	-	-16.57M
Long-Term Debt Repaid, Total	-13.93M	-152M	-29.01M	-30.39M	-173M
Total Debt Repaid	-16.42M	-152M	-31.83M	-30.39M	-190M
Issuance of Common Stock	-	40.94M	-	-	-
Repurchase of Common Stock	-463K	-3.15M	-2.98M	-1.49M	-849K
Common Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Other Financing Activities, Total	-61K	-27K	-10K	-24K	-
Cash from Financing	-2.68M	72.24M	-18.23M	9.2M	-12.66M
Miscellaneous Cash Flow Adjustments	-	-	-	-1K	1K
Net Change in Cash	-2.95M	16.43M	-9.86M	-8.7M	3.98M
Supplemental Items
Cash Interest Paid	1.28M	2.16M	2.31M	7.89M	9.84M
Cash Income Tax Paid (Refund)	4.16M	3.68M	6.92M	7.24M	8.69M
Levered Free Cash Flow	13.69M	15.28M	26.58M	46.05M	9M
Unlevered Free Cash Flow	15.28M	17.91M	29.21M	52.48M	17.71M
Change In Net Working Capital	-2.96M	-5.92M	-898K	-20.76M	17.1M
Net Debt Issued / Repaid	-2.15M	34.48M	-15.24M	10.72M	-11.81M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	2.89	3.89	3.92	3.8	3.77
Return on Total Capital	4.02	5.49	5.54	5.57	5.43
Return On Equity %	5.96	8.12	7.94	7.2	6.89
Return on Common Equity	5.96	8.12	7.94	7.2	6.99
Margin Analysis
Gross Profit Margin %	20.98	22.45	22.28	22.04	21.34
SG&A Margin	0.83	0.24	0.26	0.24	0.22
EBITDA Margin %	14.3	16.49	17.2	16.83	15.16
EBITA Margin %	10.01	12.12	12.54	12.04	10.67
EBIT Margin %	9.95	12.01	12.46	11.98	10.63
Income From Continuing Operations Margin %	5.7	6.69	6.7	5.7	4.67
Net Income Margin %	5.7	6.69	6.69	5.68	4.64
Net Avail. For Common Margin %	5.7	6.69	6.69	5.68	4.64
Normalized Net Income Margin	6.04	6.56	6.94	5.71	4.82
Levered Free Cash Flow Margin	6.62	5.42	8.31	12.58	1.92
Unlevered Free Cash Flow Margin	7.39	6.36	9.13	14.33	3.79
Asset Turnover
Asset Turnover	0.46	0.52	0.5	0.51	0.57
Fixed Assets Turnover	1.32	1.5	1.46	1.54	1.71
Receivables Turnover (Average Receivables)	3.57	4.08	4.16	4.07	4.32
Inventory Turnover (Average Inventory)	50.85	55.95	58.08	58.1	63.13
Short Term Liquidity
Current Ratio	1.02	1	0.92	0.71	1.14
Quick Ratio	0.94	0.93	0.86	0.66	1.02
Operating Cash Flow to Current Liabilities	0.24	0.28	0.33	0.24	0.24
Days Sales Outstanding (Average Receivables)	102.49	89.41	87.66	89.73	84.67
Days Outstanding Inventory (Average Inventory)	7.2	6.52	6.28	6.28	5.8
Average Days Payable Outstanding	77.26	68.33	71.44	88.42	86.56
Cash Conversion Cycle (Average Days)	32.42	27.61	22.51	7.58	3.91
Long Term Solvency
Total Debt/Equity	60.24	70.41	63.18	75.78	76.86
Total Debt / Total Capital	37.59	41.32	38.72	43.11	43.46
LT Debt/Equity	44.21	52.98	47.32	54.47	67.04
Long-Term Debt / Total Capital	27.59	31.09	29	30.99	37.91
Total Liabilities / Total Assets	55.81	58.39	56.78	62.21	60.82
EBIT / Interest Expense	8.11	8.03	9.48	4.26	3.57
EBITDA / Interest Expense	12.56	11.63	13.69	6.26	5.3
(EBITDA - Capex) / Interest Expense	8.23	6.12	10.4	4.76	3.99
Total Debt / EBITDA	3.84	3.75	3.07	3.54	3.47
Net Debt / EBITDA	3.06	2.91	2.52	3.19	3.11
Total Debt / (EBITDA - Capex)	5.87	7.12	4.04	4.65	4.61
Net Debt / (EBITDA - Capex)	4.68	5.52	3.32	4.19	4.13
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	6.39	35.21	13.12	14.4	27.76
Gross Profit, 1 Yr. Growth %	-0.78	61.16	17.82	17.53	24.81
EBITDA, 1 Yr. Growth %	-10.92	62.61	14.46	13.89	9.75
EBITA, 1 Yr. Growth %	-11.25	96.25	20.67	20.25	12.78
EBIT, 1 Yr. Growth %	-9.97	99.32	22.37	22.83	15.14
Earnings From Cont. Operations, 1 Yr. Growth %	-10.41	59.9	13.75	-2.61	4.67
Net Income, 1 Yr. Growth %	-10.36	59.87	13.76	-2.93	4.34
Normalized Net Income, 1 Yr. Growth %	-12.97	103.97	25.56	6.51	10.02
Diluted EPS Before Extra, 1 Yr. Growth %	-12.5	50	14.29	-25	33.33
Accounts Receivable, 1 Yr. Growth %	12.9	21.67	2.35	32.05	11.73
Inventory, 1 Yr. Growth %	18.65	23.95	-1.8	31.55	8.78
Net Property, Plant and Equip., 1 Yr. Growth %	2.54	36.34	2.22	14.05	16.13
Total Assets, 1 Yr. Growth %	6.53	36.24	3.08	23.29	6.78
Tangible Book Value, 1 Yr. Growth %	-43.85	-165.67	48.23	813.62	-33.76
Common Equity, 1 Yr. Growth %	5.85	28.2	7.15	7.1	7.87
Cash From Operations, 1 Yr. Growth %	21.36	58.14	20.81	13.99	-30.02
Capital Expenditures, 1 Yr. Growth %	24.79	110.99	-40.36	11.59	18.48
Levered Free Cash Flow, 1 Yr. Growth %	46.15	33.64	83.37	91.93	-53.46
Unlevered Free Cash Flow, 1 Yr. Growth %	43.39	37.59	70.51	97.15	-31.32
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	15.71	20.39	23.94	13.76	20.9
Gross Profit, 2 Yr. CAGR %	8.26	20.26	34.78	15.48	20.59
EBITDA, 2 Yr. CAGR %	3.62	18.29	38.84	13.17	14.51
EBITA, 2 Yr. CAGR %	-2.24	20.97	51.86	15.16	16.69
EBIT, 2 Yr. CAGR %	-1.77	21.64	53.26	16.06	17.97
Earnings From Cont. Operations, 2 Yr. CAGR %	-8.48	19.69	34.86	5.25	0.96
Net Income, 2 Yr. CAGR %	-6.87	19.71	34.86	5.09	0.64
Normalized Net Income, 2 Yr. CAGR %	-0.24	13.46	56.61	8.7	7.11
Diluted EPS Before Extra, 2 Yr. CAGR %	-8.07	14.56	30.93	-7.42	0
Accounts Receivable, 2 Yr. CAGR %	32.01	17.2	11.6	16.26	21.47
Inventory, 2 Yr. CAGR %	25.38	21.27	10.32	13.66	19.62
Net Property, Plant and Equip., 2 Yr. CAGR %	30.72	18.24	18.05	7.97	15.08
Total Assets, 2 Yr. CAGR %	26.1	20.47	18.51	12.73	14.74
Tangible Book Value, 2 Yr. CAGR %	-73.89	-39.28	-1.34	268	146
Common Equity, 2 Yr. CAGR %	6.58	16.49	17.2	7.12	7.48
Cash From Operations, 2 Yr. CAGR %	11.36	38.53	38.22	17.35	-10.69
Capital Expenditures, 2 Yr. CAGR %	10.35	62.26	12.17	-18.42	14.98
Levered Free Cash Flow, 2 Yr. CAGR %	9.2	27.71	52.48	78.23	-38.74
Unlevered Free Cash Flow, 2 Yr. CAGR %	11.91	29.67	49.79	75.04	-18.44
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	15.01	22.18	18.09	20.68	18.25
Gross Profit, 3 Yr. CAGR %	10.32	19.55	17.69	27.16	18.16
EBITDA, 3 Yr. CAGR %	6.46	19.03	18.37	29.21	13.82
EBITA, 3 Yr. CAGR %	2.68	16.37	19.81	36.34	14.51
EBIT, 3 Yr. CAGR %	3.08	16.61	20.36	37.25	15.13
Earnings From Cont. Operations, 3 Yr. CAGR %	-1.44	10.23	17.68	20.99	5.05
Net Income, 3 Yr. CAGR %	-1.27	11.51	17.7	20.86	4.84
Normalized Net Income, 3 Yr. CAGR %	2.1	13.75	15.68	32.15	8.37
Diluted EPS Before Extra, 3 Yr. CAGR %	-11.21	8.23	14.47	8.74	4.55
Accounts Receivable, 3 Yr. CAGR %	16.94	28.47	12.03	18.04	14.73
Inventory, 3 Yr. CAGR %	14.03	24.9	13.03	16.99	12.01
Net Property, Plant and Equip., 3 Yr. CAGR %	20.95	32.57	12.64	16.7	10.63
Total Assets, 3 Yr. CAGR %	28.59	29.4	14.37	20.08	10.71
Tangible Book Value, 3 Yr. CAGR %	-41.17	-64.49	-18.24	107.18	107.78
Common Equity, 3 Yr. CAGR %	28.72	13.35	13.29	13.73	7.37
Cash From Operations, 3 Yr. CAGR %	-5.03	25.17	32.35	29.62	-1.23
Capital Expenditures, 3 Yr. CAGR %	63.19	36.96	16.23	11.98	-7.62
Levered Free Cash Flow, 3 Yr. CAGR %	-8.43	10	41.58	59.11	-14.68
Unlevered Free Cash Flow, 3 Yr. CAGR %	-5.98	13.66	39.96	59.16	1.11
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	10.41	17.85	18.68	18.85	19.2
Gross Profit, 5 Yr. CAGR %	9.63	19.6	17.14	16.86	17.95
EBITDA, 5 Yr. CAGR %	9.95	23.14	17.57	17.47	16.4
EBITA, 5 Yr. CAGR %	9.41	24.77	15.97	15.27	16.44
EBIT, 5 Yr. CAGR %	9.32	24.6	16.23	15.52	16.81
Earnings From Cont. Operations, 5 Yr. CAGR %	11.85	27.32	11.73	8.21	10.68
Net Income, 5 Yr. CAGR %	12.25	27.96	11.85	8.9	10.55
Normalized Net Income, 5 Yr. CAGR %	10.49	23.65	13.61	10.74	9.43
Diluted EPS Before Extra, 5 Yr. CAGR %	4.91	18.07	3.71	1.68	8.45
Accounts Receivable, 5 Yr. CAGR %	10.38	15.65	14.77	23.44	15.71
Inventory, 5 Yr. CAGR %	3.78	9.64	12.53	20.28	15.62
Net Property, Plant and Equip., 5 Yr. CAGR %	14.25	21.69	19.78	22.12	13.61
Total Assets, 5 Yr. CAGR %	22.17	29.68	24.46	22.45	14.52
Tangible Book Value, 5 Yr. CAGR %	-30.19	-36.44	-27.65	-9.52	27.03
Common Equity, 5 Yr. CAGR %	22.42	27.68	23.98	10.82	10.93
Cash From Operations, 5 Yr. CAGR %	8.28	24.07	10.35	21.98	13.09
Capital Expenditures, 5 Yr. CAGR %	20.64	37.71	40.47	11.32	15.73
Levered Free Cash Flow, 5 Yr. CAGR %	-	16.16	8.32	32.03	-0.79
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	18.31	9.71	33.89	10.7